Rating Agencies

Share recommendations

Made with ❤ von BGFL
#BGFLapp * beta

Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.

26.06.2024 09:01AM
Study issued by NuWays AG

Westwing Group SE (von NuWays AG): Kaufen

Kaufen
On track to strengthen the premium H&L one-stop shop in 2024 While 2024 revenue and active customer growth will be affected by headwinds in its International segment resulting from a deliberate and strategic adjustment of the product assortments in Spain and Italy by a low to mid single-digit percentage figure to enhance future scalability [ … ]
24.06.2024 12:01PM
Study issued by GBC AG

Verve Group SE (von GBC AG): BUY

BUY
Jun acquisition ensures significant sales and earnings growth and a significant strengthening of the demand side; the integration of the acquisition opens up considerable sales synergies; significant increase in forecasts and price target; 'BUY' rating confirmed   On 18 June 2024, Verve Group SE (Verve) announced the signing of an agreement  [ … ]
24.06.2024 11:01AM

APONTIS PHARMA AG (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research on 24/06/2024 initiated coverage on APONTIS PHARMA AG (ISIN: DE000A3CMGM5/ Bloomberg: APPH GR). Analyst Christian Orquera placed a BUY rating on the stock, with a EUR 17.00 price target. Abstract: Apontis Pharma AG (Apontis) is a leading specialty pharmaceutical company focusing on the development and marketing of a [ … ]
24.06.2024 09:16AM

Verve Group SE (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE0018538068) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 4,10 auf EUR 4,90. Zusammenfassung: Die kürzlich umbenannte Verve Group SE hat mit der strategischen Übernahme der Jun Group, ein [ … ]
19.06.2024 09:01AM
Study issued by NuWays AG

LAIQON AG (von NuWays AG): Kaufen

Kaufen
High debt-to-equity conversion and successful capital increase Topic: in May, LAIQON's 20/24 convertible showed a 80% conversion rate and a 5.3% cash capital increase has been placed successfully at a premium. Both capital measures underpin the investor's appetite for LAIQON's equity story. High debt to equity conversion: the conversion windo [ … ]
13.06.2024 10:41AM

Formycon AG (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research has published a research update on Formycon AG (ISIN: DE000A1EWVY8). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 105.00 to EUR 80.00. Abstract: The Formycon share price has fallen by more than 40% since the beginning of 2023, mainly because of lower than expected royalty i [ … ]
12.06.2024 02:46PM

MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 81,00 auf EUR 113,00. Zusammenfassung: Der Nettoinventarwert (NAV) für Q1 stieg um etwa 34% J/J auf €252 Mio., blieb aber sei [ … ]
11.06.2024 10:11AM
Study issued by NuWays AG

R. STAHL AG (von NuWays AG): Kaufen

Kaufen
Operating turnaround intact thanks to several structural trends LNG remains a material mid-term growth opportunity. R. Stahl is the globally leading provider of explosion protection for LNG tankers, terminals and liquification/regassification plants (25-75% market shares). Independence from Russian energy imports lead to a rising demand for LNG [ … ]
06.06.2024 03:22PM

M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 18,00 auf EUR 28,00. Zusammenfassung: Die endgültigen Zahlen für 2023 lagen nahe bei den vorläufigen Werten und bestäti [ … ]
06.06.2024 09:01AM
Study issued by NuWays AG

DEMIRE AG (von NuWays AG): Halten

Halten
DEMIRE reaches agreement with bondholders Yesterday, DEMIRE released an ad-hoc stating that the company has reached an agreement with a group of bondholders (ad-hoc group), who represent the majority of the outstanding principal amount of the bond (€ 499m). It is aimed to close the agreement as soon as possible. Here are the key components [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
          Rating Agencies          
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL